New Research Confirms HPV Vaccination Prevents Cervical Cancer

Human papillomavirus (HPV) is a family of common viruses, some of which are classified as "high-risk" and can lead to various cancers, including cervical cancer, which is the fourth most common cancer among women globally, resulting in over 300,000 deaths annually. The recent Cochrane reviews provide strong evidence that HPV vaccination significantly reduces the risk of developing cervical cancer and pre-cancerous changes, particularly when administered to young individuals before exposure to the virus.

CochraneCochraneThe HPV vaccine does prevent cervical cancer, scientists confirm

Two comprehensive reviews analyzed data from numerous studies, including randomized controlled trials and observational studies involving over 132 million participants. The first review, encompassing 60 studies with 157,414 participants, confirmed that all HPV vaccines, including Cervarix, Gardasil, and Gardasil-9, effectively prevent infections that can lead to cancer. Notably, girls vaccinated before the age of 16 were found to be 80% less likely to develop cervical cancer compared to their unvaccinated peers.

The HPV vaccine does prevent cervical cancer, scientists confirmCochraneCochrane

The second review corroborated these findings through population-level studies, demonstrating a clear reduction in cervical cancer and pre-cancerous changes following the introduction of the vaccine. Additionally, the reviews highlighted that the vaccines also significantly decreased the incidence of anogenital warts.

The HPV vaccine does prevent cervical cancer, scientists confirmCochrane

The reviews indicated that HPV vaccines are generally safe, with only minor side effects such as soreness at the injection site. There was no evidence linking the vaccine to serious adverse effects, including infertility or chronic fatigue syndrome, which have been subjects of misinformation.

Cochrane

The findings support global health recommendations to vaccinate both girls and boys before the age of 16 to maximize protection against HPV-related cancers. Vaccination is most effective when administered prior to sexual debut, thereby preventing initial exposure to the virus.

CochraneCochraneThe HPV vaccine does prevent cervical cancer, scientists confirm

Dr. Jo Morrison, a senior author of the reviews, emphasized the importance of early vaccination, stating, “These reviews make it clear that HPV vaccination in early adolescence can prevent cancer and save lives.” The reviews also advocate for the inclusion of boys in vaccination programs to enhance herd immunity and provide broader protection.

The HPV vaccine does prevent cervical cancer, scientists confirm

Despite the positive findings, the authors noted gaps in research, particularly in low- and middle-income countries where cervical cancer rates are higher and screening programs are less accessible. They called for more studies in these regions to fully understand the vaccine's impact.

Cochrane

The Cochrane reviews present compelling evidence that HPV vaccination is a crucial public health measure capable of preventing cervical cancer and related diseases. As vaccination rates have declined, partly due to misinformation, the need for continued education and outreach is critical. Ongoing research will further elucidate the long-term effects of HPV vaccination on various cancers that develop later in life, reinforcing the vaccine's role in cancer prevention strategies worldwide.

CityLabCochraneCochrane

“Clinical trials cannot yet give us the whole picture on cervical cancer, as HPV-related cancers can take many years to develop,” — Hanna Bergman, Co-Lead Author

Cochrane

“We now have clear and consistent evidence from around the world that HPV vaccination prevents cervical cancer,” — Nicholas Henschke, Co-Lead Author

Cochrane

“Vaccinating boys as well as girls boosts protection for everyone.” — Dr. Jo Morrison, Senior Author

Cochrane

“The phenomenon of misinformation leading to reduced vaccination rates is worldwide, and there have been vaccine scares in other countries that have had really very massive impacts on vaccine uptake,” — Jo Morrison, Gynecological Oncology Consultant

CityLab